Holocene Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541K | Hold |
1,216
| – | – | ﹤0.01% | 688 |
|
|
2025
Q1 | $590K | Sell |
1,216
-327
| -21% | -$159K | ﹤0.01% | 658 |
|
|
2024
Q4 | $621K | Buy |
+1,543
| New | +$621K | ﹤0.01% | 690 |
|
|
2022
Q3 | – | Sell |
-500,130
| Closed | -$141M | – | 967 |
|
|
2022
Q2 | $141M | Buy |
500,130
+359
| +0.1% | +$101K | 0.85% | 31 |
|
|
2022
Q1 | $130M | Buy |
+499,771
| New | +$130M | 0.68% | 44 |
|
|
2021
Q3 | – | Sell |
-2,693
| Closed | -$543K | – | 961 |
|
|
2021
Q2 | $543K | Sell |
2,693
-3,078
| -53% | -$621K | ﹤0.01% | 709 |
|
|
2021
Q1 | $1.24M | Buy |
5,771
+1,997
| +53% | +$429K | 0.01% | 661 |
|
|
2020
Q4 | $892K | Buy |
+3,774
| New | +$892K | 0.01% | 548 |
|
|
2020
Q3 | – | Sell |
-118,153
| Closed | -$34.3M | – | 784 |
|
|
2020
Q2 | $34.3M | Sell |
118,153
-318,634
| -73% | -$92.5M | 0.3% | 94 |
|
|
2020
Q1 | $104M | Sell |
436,787
-66,148
| -13% | -$15.7M | 1.12% | 25 |
|
|
2019
Q4 | $110M | Buy |
502,935
+64,252
| +15% | +$14.1M | 0.99% | 22 |
|
|
2019
Q3 | $74.3M | Buy |
+438,683
| New | +$74.3M | 0.77% | 40 |
|
|
2018
Q2 | – | Sell |
-1,346
| Closed | -$219K | – | 734 |
|
|
2018
Q1 | $219K | Buy |
+1,346
| New | +$219K | ﹤0.01% | 495 |
|